*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
E850 - Non-neuropathic heredofamilial amyloidosis - as a primary diagnosis code | E850 - Non-neuropathic heredofamilial amyloidosis - as a primary or secondary diagnosis code | |
---|---|---|
OUTCOMES | ||
Avg. LOS | 6.55 | |
Readmission Rate (%) | 30.1 | |
Unplanned Readmission Rate (%) | NA | |
Mortality Rate (%) | ||
SNF Discharge Rate (%) | ||
Home Discharge Rate (%) | ||
PAYMENTS AND CHARGES | ||
Total Medicare Payments | ||
Payment Per Day | ||
Payment Per Hospitalization | ||
Total Medicare Charges | ||
Avg. Charges | ||
MARKET SIZING & INCIDENCE RATES | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
Total Medicare Hospitalizations after Exclusion |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 546: CONNECTIVE TISSUE DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 545: CONNECTIVE TISSUE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 547: CONNECTIVE TISSUE DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|
Total Hospitalizations at DRG | 14,526 | ||
Total Hospitalizations with ICD E850 - Non-neuropathic heredofamilial amyloidosis | 17 | ||
DRG Share of Total Hospitalizations | 0.04 | ||
% of Total ICD E850 - Non-neuropathic heredofamilial amyloidosis in DRG | 38.64 | ||
Avg LOS at DRG | 5.12 | ||
Avg LOS with ICD E850 - Non-neuropathic heredofamilial amyloidosis | 4.0 | ||
Readmission Rate at DRG | 23.17 | ||
Readmission Rate with ICD E850 - Non-neuropathic heredofamilial amyloidosis | NA | ||
Unplanned Readmission Rate at DRG | 15.83 | ||
Unplanned Readmission Rate with ICD E850 - Non-neuropathic heredofamilial amyloidosis | NA | ||
Total Medicare payments at DRG | $123,348,417 | ||
Total Medicare payments with ICD E850 - Non-neuropathic heredofamilial amyloidosis | $138,213 | ||
Total Medicare payment per Day at DRG | $1,658 | ||
Total Medicare payment per Day with ICD E850 - Non-neuropathic heredofamilial amyloidosis | $2,033 | ||
Total Medicare payment per Hospitalization at DRG | $8,492 | ||
Total Medicare payment per Hospitalization with ICD E850 - Non-neuropathic heredofamilial amyloidosis | $8,130 | ||
Total Medicare Charges at DRG | $565,151,481 | ||
Total Medicare Charges with ICD E850 - Non-neuropathic heredofamilial amyloidosis | $441,388 | ||
Avg Charges at DRG | $38,906 | ||
Avg Charges with ICD E850 - Non-neuropathic heredofamilial amyloidosis | $25,964 | ||
Mortality Rate at DRG | 0.34 | ||
Mortality Rate with ICD E850 - Non-neuropathic heredofamilial amyloidosis | NA | ||
SNF Discharge Rate at DRG | 16.01 | ||
SNF Discharge Rate with ICD E850 - Non-neuropathic heredofamilial amyloidosis | NA | ||
Home Discharge Rate at DRG | 53.61 | ||
Home Discharge Rate with ICD E850 - Non-neuropathic heredofamilial amyloidosis | 70.59 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 546: CONNECTIVE TISSUE DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 545: CONNECTIVE TISSUE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 547: CONNECTIVE TISSUE DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
---|---|---|---|---|---|
Total Hospitalizations at DRG | 1,808,415 | ||||
Total Hospitalizations with ICD E850 - Non-neuropathic heredofamilial amyloidosis | 25 | ||||
DRG Share of Total Hospitalizations | 5.5 | ||||
% of Total ICD E850 - Non-neuropathic heredofamilial amyloidosis in DRG | 7.44 | ||||
Avg LOS at DRG | 6.34 | ||||
Avg LOS with ICD E850 - Non-neuropathic heredofamilial amyloidosis | 7.08 | ||||
Readmission Rate at DRG | 24.2 | ||||
Readmission Rate with ICD E850 - Non-neuropathic heredofamilial amyloidosis | NA | ||||
Unplanned Readmission Rate at DRG | 16.78 | ||||
Unplanned Readmission Rate with ICD E850 - Non-neuropathic heredofamilial amyloidosis | NA | ||||
Total Medicare payments at DRG | $21,288,214,047 | ||||
Total Medicare payments with ICD E850 - Non-neuropathic heredofamilial amyloidosis | $339,368 | ||||
Total Medicare payment per Day at DRG | $1,857 | ||||
Total Medicare payment per Day with ICD E850 - Non-neuropathic heredofamilial amyloidosis | $1,917 | ||||
Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
Total Medicare payment per Hospitalization with ICD E850 - Non-neuropathic heredofamilial amyloidosis | $13,575 | ||||
Total Medicare Charges at DRG | $107,155,481,388 | ||||
Total Medicare Charges with ICD E850 - Non-neuropathic heredofamilial amyloidosis | $1,964,416 | ||||
Avg Charges at DRG | $59,254 | ||||
Avg Charges with ICD E850 - Non-neuropathic heredofamilial amyloidosis | $78,577 | ||||
Mortality Rate at DRG | 12.11 | ||||
Mortality Rate with ICD E850 - Non-neuropathic heredofamilial amyloidosis | NA | ||||
SNF Discharge Rate at DRG | 27.18 | ||||
SNF Discharge Rate with ICD E850 - Non-neuropathic heredofamilial amyloidosis | NA | ||||
Home Discharge Rate at DRG | 25.81 | ||||
Home Discharge Rate with ICD E850 - Non-neuropathic heredofamilial amyloidosis | 44.0 |